The regenerative capacity of the liver is essential for recovery from surgical resection or injuries induced by trauma or toxins. During liver regeneration, the concentration of nicotinamide adenine dinucleotide (NAD) falls, at least in part due to metabolic competition for precursors. To test whether NAD availability restricts the rate of liver regeneration, we supplied nicotinamide riboside (NR), an NAD precursor, in the drinking water of mice subjected to partial hepatectomy. NR increased DNA synthesis, mitotic index, and mass restoration in the regenerating livers. Intriguingly, NR also ameliorated the steatosis that normally accompanies liver regeneration. To distinguish the role of hepatocyte NAD levels from any systemic effects of NR, we generated mice overexpressing nicotinamide phosphoribosyltransferase, a rate-limiting enzyme for NAD synthesis, specifically in the liver. Nicotinamide phosphoribosyltransferase overexpressing mice were mildly hyperglycemic at baseline and, similar to mice treated with NR, exhibited enhanced liver regeneration and reduced steatosis following partial hepatectomy. Conversely, mice lacking nicotinamide phosphoribosyltransferase in hepatocytes exhibited impaired regenerative capacity that was completely rescued by administering NR. CONCLUSION: NAD availability is limiting during liver regeneration, and supplementation with precursors such as NR may be therapeutic in settings of acute liver injury. (Hepatology 2017;65:616-630).
The regenerative capacity of the liver is essential for recovery from surgical resection or injuries induced by trauma or toxins. During liver regeneration, the concentration of nicotinamide adenine dinucleotide (NAD) falls, at least in part due to metabolic competition for precursors. To test whether NAD availability restricts the rate of liver regeneration, we supplied nicotinamide riboside (NR), an NAD precursor, in the drinking water of mice subjected to partial hepatectomy. NR increased DNA synthesis, mitotic index, and mass restoration in the regenerating livers. Intriguingly, NR also ameliorated the steatosis that normally accompanies liver regeneration. To distinguish the role of hepatocyte NAD levels from any systemic effects of NR, we generated mice overexpressing nicotinamide phosphoribosyltransferase, a rate-limiting enzyme for NAD synthesis, specifically in the liver. Nicotinamide phosphoribosyltransferase overexpressing mice were mildly hyperglycemic at baseline and, similar to mice treated with NR, exhibited enhanced liver regeneration and reduced steatosis following partial hepatectomy. Conversely, mice lacking nicotinamide phosphoribosyltransferase in hepatocytes exhibited impaired regenerative capacity that was completely rescued by administering NR. CONCLUSION:NAD availability is limiting during liver regeneration, and supplementation with precursors such as NR may be therapeutic in settings of acute liver injury. (Hepatology 2017;65:616-630).
Authors: Juan L García-Rodríguez; Lucía Barbier-Torres; Sara Fernández-Álvarez; Virginia Gutiérrez-de Juan; María J Monte; Emina Halilbasic; Daniel Herranz; Luis Álvarez; Patricia Aspichueta; Jose J G Marín; Michael Trauner; Jose M Mato; Manuel Serrano; Naiara Beraza; María Luz Martínez-Chantar Journal: Hepatology Date: 2014-03-31 Impact factor: 17.425
Authors: David W Frederick; James G Davis; Antonio Dávila; Beamon Agarwal; Shaday Michan; Michelle A Puchowicz; Eiko Nakamaru-Ogiso; Joseph A Baur Journal: J Biol Chem Date: 2014-11-19 Impact factor: 5.157
Authors: Yumi Imai; Gladys M Varela; Malaka B Jackson; Mark J Graham; Rosanne M Crooke; Rexford S Ahima Journal: Gastroenterology Date: 2007-02-23 Impact factor: 22.682
Authors: Daniel Kraus; Qin Yang; Dong Kong; Alexander S Banks; Lin Zhang; Joseph T Rodgers; Eija Pirinen; Thomas C Pulinilkunnil; Fengying Gong; Ya-chin Wang; Yana Cen; Anthony A Sauve; John M Asara; Odile D Peroni; Brett P Monia; Sanjay Bhanot; Leena Alhonen; Pere Puigserver; Barbara B Kahn Journal: Nature Date: 2014-04-10 Impact factor: 49.962
Authors: Hisayuki Amano; Arindam Chaudhury; Cristian Rodriguez-Aguayo; Lan Lu; Viktor Akhanov; Andre Catic; Yury V Popov; Eric Verdin; Hannah Johnson; Fabio Stossi; David A Sinclair; Eiko Nakamaru-Ogiso; Gabriel Lopez-Berestein; Jeffrey T Chang; Joel R Neilson; Alan Meeker; Milton Finegold; Joseph A Baur; Ergun Sahin Journal: Cell Metab Date: 2019-03-28 Impact factor: 27.287
Authors: Jian Zheng; Ilya G Glezerman; Eran Sadot; Anjuli McNeil; Cristina Zarama; Mithat Gönen; John Creasy; Linda M Pak; Vinod P Balachandran; Michael I D'Angelica; Peter J Allen; Ronald P DeMatteo; T Peter Kingham; William R Jarnagin; Edgar A Jaimes Journal: J Am Coll Surg Date: 2017-07-06 Impact factor: 6.113
Authors: Morten Dall; Samuel A J Trammell; Magnus Asping; Anna S Hassing; Marianne Agerholm; Sara G Vienberg; Matthew P Gillum; Steen Larsen; Jonas T Treebak Journal: J Biol Chem Date: 2019-07-18 Impact factor: 5.157
Authors: Yitzhak Reizel; Ashleigh Morgan; Long Gao; Jonathan Schug; Sarmistha Mukherjee; Meilín Fernández García; Greg Donahue; Joseph A Baur; Kenneth S Zaret; Klaus H Kaestner Journal: Dev Cell Date: 2021-02-25 Impact factor: 12.270